Simultaneous engagement of the activatory receptors NKG2D and CD3 for retargeting of effector cells to CD33-positive malignant cells

被引:32
作者
Stamova, S. [1 ]
Cartellieri, M. [1 ]
Feldmann, A. [1 ]
Bippes, C. C. [1 ]
Bartsch, H. [1 ]
Wehner, R. [1 ]
Schmitz, M. [1 ]
von Bonin, M. [2 ]
Bornhaeuser, M. [2 ]
Ehninger, G. [2 ]
Rieber, E. P. [1 ]
Bachmann, M. [1 ,3 ]
机构
[1] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Immunol, Dresden, Germany
[2] Tech Univ Dresden, Med Fac Carl Gustav Carus, Univ Klinikum Dresden, Med Klin & Poliklin 1, Dresden, Germany
[3] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, Dresden, Germany
关键词
T-CELLS;
D O I
10.1038/leu.2011.42
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1053 / 1056
页数:5
相关论文
共 8 条
[1]  
Baeuerle PA, 2009, CURR OPIN MOL THER, V11, P22
[2]  
Bross PF, 2001, CLIN CANCER RES, V7, P1490
[3]   IDENTIFICATION OF LA RIBONUCLEOPROTEINS AS A COMPONENT OF INTERCHROMATIN GRANULES [J].
CARMOFONSECA, M ;
PFEIFER, K ;
SCHRODER, HC ;
VAZ, MF ;
FONSECA, JE ;
MULLER, WEG ;
BACHMANN, M .
EXPERIMENTAL CELL RESEARCH, 1989, 185 (01) :73-85
[4]   Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells [J].
Groh, V ;
Rhinehart, R ;
Randolph-Habecker, J ;
Topp, MS ;
Riddell, SR ;
Spies, T .
NATURE IMMUNOLOGY, 2001, 2 (03) :255-260
[5]   TNK cells (NKG2D+ CD8+ or CD4+ T lymphocytes) in the control of human tumors [J].
Maccalli, Cristina ;
Scaramuzza, Samantha ;
Parmiani, Giorgio .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (05) :801-808
[6]   Siglecs as targets for therapy in immune-cell-mediated disease [J].
O'Reilly, Mary K. ;
Paulson, James C. .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2009, 30 (05) :240-248
[7]   Effective Elimination of Acute Myeloid Leukemic Cells by Recombinant Bispecific Antibody Derivatives Directed Against CD33 and CD16 [J].
Singer, Heiko ;
Kellner, Christian ;
Lanig, Harald ;
Aigner, Michael ;
Stockmeyer, Bernhard ;
Oduncu, Fuat ;
Schwemmlein, Michael ;
Stein, Christoph ;
Mentz, Kristin ;
Mackensen, Andreas ;
Fey, Georg H. .
JOURNAL OF IMMUNOTHERAPY, 2010, 33 (06) :599-608
[8]   A novel bispecific protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in vitro and in vivo [J].
von Strandmann, EP ;
Hansen, HP ;
Reiners, KS ;
Schnell, R ;
Borchmann, P ;
Merkert, S ;
Simhadri, VR ;
Draube, A ;
Reiser, M ;
Purr, I ;
Hallek, M ;
Engert, A .
BLOOD, 2006, 107 (05) :1955-1962